ORAMED PHARMACEUTICALS INC. Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Percent
ORAMED PHARMACEUTICALS INC. (ORMP) reported Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Percent of 50.00% for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-06.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsOther · last filed 2023-03-06
- ORAMED PHARMACEUTICALS INC. effective income tax rate reconciliation, tax settlement, other, percent for fiscal 2022 was 50.00%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Percent 12 month |
|---|---|
| 2022-12-31 | 50.00% 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |